Elsevier

Journal of Infection

Volume 63, Issue 4, October 2011, Pages 295-299
Journal of Infection

Pandemic (H1N1) 2009 virus infection: Persistent viral shedding after Oseltamivir treatment

https://doi.org/10.1016/j.jinf.2011.08.005Get rights and content

Summary

Objectives

To study pandemic (H1N1) 2009 virological outcomes after Oseltamivir treatment in confirmed cases of pandemic (H1N1) 2009 virus infections. A hospital-based cohort study was conducted in south Thailand, between June and September 2009.

Methods

Throat/swab specimens were tested by real-time reverse transcriptase polymerase chain reaction (rRT-PCR) for pandemic (H1N1) 2009. All 357 confirmed cases (122 inpatients, 235 outpatients), whose received a 5-day Oseltamivir treatment. Post-treatment virological follow-up was performed in 91 eligible cases. The NA gene was screened for the H275Y mutation responsible for Oseltamivir resistance.

Results

Thirty-three of 91 patients (36%) had underlying diseases. The duration from the onset of illness to the detection of virus ranged 1–14 days (median 3 days). The rRT-PCR was positive on day 5 of treatment in 24 of 91 patients (26%). Patients with underlying diseases had a higher proportion of post-treatment positive test than those without underlying diseases (15/33 vs 9/58). The rRT-PCR-confirmed viruses detected in all 125 throat swab specimens did not show evidence suggesting Oseltamivir resistance.

Conclusions

Prolonged presence of pandemic (H1N1) 2009 detected by rRT-PCR was found. An extended course of antiviral treatment should be considered in patients with underlying diseases and severe clinical symptoms.

Introduction

Although there are some published reports on the duration of shedding of seasonal influenza virus after treatment with Oseltamivir, data relevant to the pandemic (H1N1) 2009 virus strain in this regard are sparse.1 In early reports, the median time of pandemic (H1N1) 2009 viral shedding determined by reverse transcriptase polymerase chain reaction (RT-PCR) was 6 days.2, 3 The estimated duration of viral shedding is based upon seasonal influenza virus infection. Infected persons should be assumed to be contagious for up to 7 days from illness onset.1 Factors associated with duration of viral shedding after antiviral therapy have not been identified. Unlike with seasonal influenza strains, resistance to Oseltamivir has not yet become a major clinical problem. However, as the virus can potentially develop resistance to Oseltamivir at any time, surveillance for Oseltamivir resistance in pandemic (H1N1) 2009 viruses should continue.

In Thailand, the first case of laboratory-confirmed pandemic (H1N1) 2009 virus was found on May 12, 2009.4 The first case in south Thailand was identified in Thungsong Hospital, Nakhon Srithammarat Province on May 28, 2009. We followed patients seen at this hospital to determine clinical response, duration of viral shedding after treatment, and the development of resistant virus.

Section snippets

Materials and methods

The study was approved by the Ethical Committee of the Thoungsong Hospital. The pandemic (H1N1) 2009 positive patients were chosen from among the patients during the investigation and treatment of influenza like illness (ILI). The objective of the study was informed and written consents were obtained from the participants and/or parents.

Patient descriptions

During the study period (28 June–15 September 2009), 28,027 patients sought care at Thungsong Hospital with 4161 (15%) patients displaying respiratory tract infection and 2516 (60%) exhibiting ILI. Throat/nasal swabs were collected from 908 (36%) of 2516 patients with ILI. Three-hundred-fifty-seven (39%) comprising 122 inpatients and 235 outpatients, of 908 patients were confirmed cases. Follow-up serial samples were available from 91 patients. Among these, the median age was 16 (range 4

Discussion

We evaluated viral shedding as determined by rRT-PCR testing in confirmed cases of pandemic (H1N1) 2009 who had received Oseltamivir treatment. We found that 26% of confirmed pandemic (H1N1) 2009 patients remained rRT-PCR positive after 5 days of Oseltamivir administraton but did not detect any drug resistance. Twelve of 91 patients (13%) were found rRT-PCR positive approximately 11 days (range 10–16 days) after symptom onset (1–8 days after complete treatment). These findings are in accordance

Acknowledgments

This work was partially supported by Higher Education Research promotion and National Research University Project of Thailand, Office of the Higher Education Commission (HR 1155A), Thailand Research Fund and Center of Excellence in Clinical Virology. We would like to thank Prof. Sayomporn Sirinavin, Dr.Wiwan sanasuttipan, Dr Sonja Jolsen, Ms. Juree Nilma, Ms. Amornrat Roento, Ms. Suppalak Jitnatham, Ms. Jaru Suwanpakdee, Dr. Ratchaneekorn Songnui, Dr. Sukit Yamwong and the entire staff of the

References (16)

There are more references available in the full text version of this article.

Cited by (0)

View full text